ITPR3 and breast cancer: In the case of breast cancer, a few studies have shown that IP3R could be the target of a variety of proteins such as Bcl-2 and cyclins that might affect cell viability by respectively suppressing apoptosis [29,30] and probably stimulating proliferation [39].